|
Jul 30
|
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
|
|
Jul 30
|
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
|
|
Jul 30
|
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
|
|
Jul 22
|
Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release
|
|
Jul 21
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Anticipated Earnings
|
|
Jul 21
|
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
|
|
Jul 21
|
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
|
|
Apr 24
|
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
|
|
Mar 4
|
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
|
|
Feb 26
|
Evotec Announces Change in Management Board
|
|
Jul 31
|
Evotec SE's (ETR:EVT) largest shareholders are retail investors with 48% ownership, institutions own 36%
|
|
Jun 12
|
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
|
|
May 22
|
Evotec Reports Q1 2024 Results and Provides Corporate Update
|
|
Apr 18
|
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
|
|
Apr 17
|
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
|
|
Apr 17
|
Evotec welcomes Aurélie Dalbiez as Chief People Officer
|
|
Feb 15
|
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
|
|
Jan 10
|
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
|
|
Jan 8
|
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
|
|
Jan 4
|
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
|